These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21670755)

  • 1. TRAIL-mediated signaling in prostate, bladder and renal cancer.
    Voelkel-Johnson C
    Nat Rev Urol; 2011 Jun; 8(8):417-27. PubMed ID: 21670755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
    Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
    Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X
    Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
    Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
    Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
    Griffith TS; Kucaba TA; O'Donnell MA; Burns J; Benetatos C; McKinlay MA; Condon S; Chunduru S
    Apoptosis; 2011 Jan; 16(1):13-26. PubMed ID: 20734142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer.
    Zhao Y; Li Y; Wang L; Yang H; Wang Q; Qi H; Li S; Zhou P; Liang P; Wang Q; Li X
    J Exp Clin Cancer Res; 2013 Feb; 32(1):10. PubMed ID: 23442927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4.
    Bi R; Deng Y; Tang C; Xuan L; Xu B; Du Y; Wang C; Wei W
    Oncol Rep; 2020 Nov; 44(5):1939-1948. PubMed ID: 33000263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
    Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
    FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy.
    Singh D; Tewari M; Singh S; Narayan G
    Future Oncol; 2021 Feb; 17(5):581-596. PubMed ID: 33401962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
    Lee YJ; Seol JW; Jeong JK; Moon MH; Park SY
    Mol Med Rep; 2011; 4(6):1255-9. PubMed ID: 21850375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
    Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
    Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
    Secchiero P; Zauli G
    Curr Opin Hematol; 2008 Jan; 15(1):42-8. PubMed ID: 18043245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-based therapeutic approaches for the treatment of pediatric malignancies.
    Gasparini C; Vecchi Brumatti L; Monasta L; Zauli G
    Curr Med Chem; 2013; 20(17):2254-71. PubMed ID: 23458616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.
    Szliszka E; Mazur B; Zydowicz G; Czuba ZP; Król W
    Folia Histochem Cytobiol; 2009; 47(4):579-85. PubMed ID: 20430723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.
    Kamat AM; Tharakan ST; Sung B; Aggarwal BB
    Cancer Res; 2009 Dec; 69(23):8958-66. PubMed ID: 19903839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.
    Holoch PA; Griffith TS
    Eur J Pharmacol; 2009 Dec; 625(1-3):63-72. PubMed ID: 19836385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of TRAIL and its receptors in benign and malignant prostate tissues.
    Sanlioglu AD; Koksal IT; Ciftcioglu A; Baykara M; Luleci G; Sanlioglu S
    J Urol; 2007 Jan; 177(1):359-64. PubMed ID: 17162091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Peuhu E; Rivero-Müller A; Stykki H; Torvaldson E; Holmbom T; Eklund P; Unkila M; Sjöholm R; Eriksson JE
    Oncogene; 2010 Feb; 29(6):898-908. PubMed ID: 19935713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.